Improvement in the Glycated Hemoglobin for Diabetic Patients as a Quality Care Adherence at Johns Hopkins Aramco Healthcare in Saudi Arabia

Introduction: Diabetes Mellitus (DM) is a complex health problem. That there is an ongoing increase pattern of DM with a ten-fold in the past three eras in Saudi Arabia. Reducing this rate, through assessing the quality of diabetes care, standardized and effective Quality Improvement (QI) performance measures are highly needed. Johns Hopkins Aramco Healthcare; JHAH revisits QI process yearly evaluating clinical needs on the key processes. It constructs a strategic plan that guarantees the desired patient outcomes and thus satisfaction. Herein, we want to describe the “Diabetes QI Practice and Performance; DQIPP” in JHAH, to share experience and quality of healthcare performance. Material and Methods: An approximate average of 15000 diabetes seen yearly in JHAH collected from Diabetic registry during the last 3 years. HbA1c testing within 6 months used as a process Key Performance Indicator (KPI), whereas “HbA1c ≥ 9.0%” used for poorly controlled diabetes as an outcome KPI. Results: Data analysis showed a significant improvement in compliance rate of both KPI measures against the set targets within JHAH, with a p value of ˂0.05. Conclusions: Working as collaborative healthcare providers to improve care management, control of diabetes and prevent the devastating complications via targeting the high-risk groups. This can impressively expand the efficiency of QI interventions and achieve a better healthcare.